News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
144,156 Results
Type
Article (4114)
Company Profile (5)
Press Release (140037)
Multimedia
Podcasts (13)
Webinars (3)
Section
Business (41126)
Career Advice (284)
Deals (6400)
Drug Delivery (10)
Drug Development (26073)
Employer Resources (13)
FDA (3877)
Job Trends (3387)
News (74052)
Policy (4695)
Tag
Academia (362)
Accelerated approval (13)
Allergies (63)
Alliances (4921)
ALS (79)
Alzheimer's disease (519)
Antibody-drug conjugate (ADC) (155)
Approvals (4199)
Artificial intelligence (206)
Autoimmune disease (77)
Automation (20)
Bankruptcy (29)
Best Places to Work (3459)
BIOSECURE Act (2)
Biosimilars (72)
Biotechnology (5)
Bladder cancer (111)
Brain cancer (21)
Breast cancer (381)
Cancer (2553)
Cardiovascular disease (194)
Career advice (215)
Career pathing (9)
CAR-T (112)
CDC (5)
Cell therapy (302)
Cervical cancer (18)
Clinical research (25267)
Collaboration (713)
Compensation (401)
Complete response letters (12)
COVID-19 (727)
CRISPR (38)
C-suite (351)
Cystic fibrosis (56)
Data (3590)
Depression (50)
Diabetes (188)
Diagnostics (1332)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (94)
Drug pricing (21)
Drug shortages (2)
Duchenne muscular dystrophy (113)
Earnings (32714)
Editorial (8)
Employer resources (13)
Events (30219)
Executive appointments (466)
FDA (5494)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (11)
Funding (655)
Gene editing (76)
Generative AI (10)
Gene therapy (218)
GLP-1 (258)
Government (658)
Grass and pollen (4)
Guidances (311)
Healthcare (3715)
HIV (34)
Huntington's disease (25)
IgA nephropathy (45)
Immunology and inflammation (56)
Immuno-oncology (23)
Indications (55)
Infectious disease (829)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (42)
Intellectual property (65)
Interviews (51)
IPO (4229)
IRA (2)
Job creations (273)
Job search strategy (178)
JPM (15)
Kidney cancer (10)
Labor market (14)
Layoffs (58)
Leadership (7)
Legal (394)
Liver cancer (35)
Longevity (2)
Lung cancer (363)
Lymphoma (217)
Machine learning (16)
Management (4)
Manufacturing (214)
MASH (76)
Medical device (2790)
Medtech (2808)
Mergers & acquisitions (2643)
Metabolic disorders (442)
Multiple sclerosis (82)
NASH (5)
Neurodegenerative disease (129)
Neuropsychiatric disorders (32)
Neuroscience (1047)
NextGen: Class of 2026 (890)
Non-profit (732)
Now hiring (2)
Obesity (171)
Opinion (41)
Ovarian cancer (98)
Pain (67)
Pancreatic cancer (112)
Parkinson's disease (108)
Partnered (4)
Patents (122)
Patient recruitment (216)
Peanut (27)
People (7361)
Pharmaceutical (3)
Pharmacy benefit managers (4)
Phase 1 (6651)
Phase 2 (10397)
Phase 3 (10532)
Pipeline (2779)
Policy (23)
Postmarket research (735)
Preclinical (1918)
Press Release (4)
Prostate cancer (156)
Psychedelics (6)
Radiopharmaceuticals (90)
Rare diseases (319)
Real estate (425)
Recruiting (3)
Regulatory (5301)
Reports (9)
Research institute (416)
Resumes & cover letters (60)
Rett syndrome (20)
RNA editing (4)
RSV (44)
Schizophrenia (82)
Series A (100)
Series B (83)
Service/supplier (1)
Sickle cell disease (43)
Special edition (5)
Spinal muscular atrophy (58)
Sponsored (7)
Startups (421)
Stomach cancer (2)
Supply chain (36)
Tariffs (11)
The Weekly (13)
Vaccines (368)
Venture capital (29)
Weight loss (82)
Women's health (24)
Worklife (5)
Date
Last 7 days (258)
Last 30 days (900)
Last 365 days (14415)
2026 (1237)
2025 (14676)
2024 (11748)
2023 (10954)
2022 (12434)
2021 (13024)
2020 (11749)
2019 (8984)
2018 (6709)
2017 (6842)
2016 (5586)
2015 (7026)
2014 (4725)
2013 (3080)
2012 (3356)
2011 (3889)
2010 (3243)
Location
Africa (95)
Alabama (24)
Alaska (1)
Arizona (36)
Arkansas (4)
Asia (7821)
Australia (1431)
California (5688)
Canada (1096)
China (415)
Colorado (216)
Connecticut (269)
Delaware (223)
Europe (19788)
Florida (534)
Georgia (137)
Hawaii (3)
Idaho (6)
Illinois (429)
India (21)
Indiana (214)
Iowa (9)
Japan (288)
Kansas (26)
Kentucky (8)
Louisiana (8)
Maine (13)
Maryland (521)
Massachusetts (4163)
Michigan (109)
Minnesota (294)
Mississippi (4)
Missouri (61)
Montana (2)
Nebraska (5)
Nevada (58)
New Hampshire (28)
New Jersey (1508)
New Mexico (9)
New York (1317)
North Carolina (540)
North Dakota (3)
Northern California (2823)
Ohio (133)
Oklahoma (7)
Oregon (10)
Pennsylvania (889)
Puerto Rico (4)
Rhode Island (13)
South America (163)
South Carolina (8)
Southern California (2173)
Tennessee (74)
Texas (821)
United States (18536)
Utah (99)
Virginia (111)
Washington D.C. (17)
Washington State (448)
West Virginia (1)
Wisconsin (86)
144,156 Results for "3m".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY26
January 29, 2026
·
7 min read
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
Nader Pourhassan, who led CytoDyn for nearly 10 years, was convicted in December 2024 of misleading investors regarding the biotech’s investigational COVID-19 and HIV drug, which artificially inflated its share price.
January 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Theralase(R) Closes $1.3 M Non-Brokered Private Placement
December 23, 2025
·
5 min read
Press Releases
3M Reports Fourth-Quarter and Full-Year 2025 Results; Initiates Full-Year 2026 Financial Guidance
January 20, 2026
·
9 min read
Press Releases
AstraZeneca’s 9M and Q3 2025 Financial Results
November 7, 2025
·
11 min read
Press Releases
FDA Approves Edwards Lifesciences’ SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
December 24, 2025
·
4 min read
Press Releases
Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience
November 27, 2025
·
3 min read
Press Releases
Transcat to Host Third Quarter Fiscal Year 2026 Conference Call and Webcast on Tuesday, February 3, 2026 at 4:30 p.m. Eastern Time
January 20, 2026
·
4 min read
Press Releases
Feinstein Institutes Awarded $3.2M Grant to Advance Polygenic Embryo Selection Research
October 23, 2025
·
3 min read
Press Releases
AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)
January 9, 2026
·
2 min read
1 of 14,416
Next
